John Machulski

John Machulski is Vice President of Engineering, Biologics, Cell and Gene Therapy at Catalent. In this role, John is responsible for planning and execution of Catalent's global capex investment program across their site manufacturing network. Prior to Catalent, John’s career spanned 30 years with Sanofi, GE Life Sciences, Lonza, Wyeth Vaccines and Johnson & Johnson in a variety of roles globally, covering commercial, engineering and operations. John holds a BS in Mechanical Engineering from Lehigh University and an MBA from LaSalle University in the US.